Freeflow Ventures is hosting a discussion on the translation of academic science – in this case human health sciences – into commercial success and practical application. President Emeritus of Caltech, Nobel Laureate, and Freeflow portfolio company co-founder David Baltimore will provide his uniquely deep and broad perspective as an institutional leader, company creator, and bench researcher. We’ll also be joined by Freeflow founders from portfolio companies in human health sharing their translational founder stories. Finally, we’ll take questions from the audience.

Watch now to learn more about how we’re translating science into innovation!